Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Clin Neurol Neurosurg. 2012 Sep 1;115(6):708–712. doi: 10.1016/j.clineuro.2012.08.019

Table 1. Baseline Patient Characteristics.

LEDD – Levodopa equivalent daily dose (mg) a dose of 100 mg of levodopa is equal to 125 mg of controlled-release levodopa is equal to 10 mg of bromocriptine is equal to 1 mg of pergolide is equal to 4 mg of ropinrirole is equal to 100 mg of amantadine is equal to 333 mg of comtan, is equal to 1 mg pramipexole is equal to 80 mg of stalevo. [31]

Patient Age (yrs) Sex Duration of PD (yrs) UPDRS III off UPDRS III on % Change UPDRS UPDRS Total Hoehn Yahr off LEDD (mg)
1* 66 F 15 40 9 77.50 63 3.0 1258
2 58 M 12 60 18 70.00 97 3.0 1750
3 50 M 8 32 12 62.50 48 2.0 1090
4 57 M 6 37 16 56.76 56 5.0 2394
5 64 F 12 55 NA NA NA 3.0 1002
6** 59 M 15 44 22 50.00 81 3.0 1140
7** 58 M 8 46 6 86.96 94 4.0 1560
8 62 F 11 54 13 75.93 94 5.0 862
9 66 M 12 44 21 52.27 77 3.0 1516
10 62 F 7 34 23 32.35 69 4.0 340
11 60 M 15 41 25 39.02 66 2.0 1376
12 54 M 7 27 11 59.26 45 2.0 2065
13 56 F 8 54 9 83.33 97 4.0 1354
14 57 F 9 58 25 56.90 89 4.0 1380
15 65 F 10 31 13 58.06 52 2.0 825
16 67 F 24 50 16 68.00 89 5.0 1180
17 55 M 9 46 23 50.00 70 3.0 1635
Mean (+/−SD) 59.8 (4.8) 9M/8F 11.1 (4.4) 43.3 (11.2) 15.9 (7.4) 60.2 (19.8) 71.4 (20.3) 3.4 (1.1) 1337 (482)
*

Excluded from the analysis (patient explanted at month 2)

**

Follow-up data missing